Radiotherapy

Today, 60% of cancer patients are treated with radiotherapy. In developed countries, the main source of exposure to ionizing radiation of human origin is medical imaging.
During radiotherapy treatments, control of the accuracy of the dose delivered, or even the reduction of doses received by the patient, are major concerns of health professionals.
The permanent objective is to reduce the risk of radio-induced cancer.
Alongside radiotherapy professionals, MEDITEST provides them with high -value technical value -added quality control products, the objective of which is risk reduction.
Beekley skin markers will guarantee you the right positioning of the patient during treatment.